What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Aristo Bio-Tech and Lifescience Limited IPO?

Aristo Bio-Tech and Lifescience Limited IPO has received a total subscription of 217.72 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Aristo Bio-Tech and Lifescience Limited

ListedSME

Chemicals & Agriculture · NSE

Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company engaged in the manufacturing, formulation, supply, and packaging of a wide range of pesticides. The company’s product portfolio includes insecticides, herbicides, fungicides, and plant growth regulators, which are distributed across India and exported to over 15 countries, including Australia, Germany, Kenya, and Vietnam. Operating in a sector focused on enhancing crop yield and quality, Aristo Bio-Tech delivers its products across 20 Indian states and supports global agricultural productivity. The company is ISO 9001:2015 certified for its quality management system and also provides contract manufacturing, job work, and toll manufacturing services for crop protection companies.

Price Band

₹72

Issue Size

₹13.05 Cr

Lot Size

1600 shares

GMP

₹43

+59.7%

Est. Listing

₹115

at current GMP

Subscribed

217.72x

overall

Open

16 Jan 2023

19 Jan 2023

Allotment

25 Jan 2023

Refund

26 Jan 2023

Demat Credit

27 Jan 2023

Listing

30 Jan 2023

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

217.72x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 217.72x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	906,250	—	0.00x
Non-Institutional (NII / HNI)	271,875	—	0.00x
Retail Individual (RII)	634,375	—	0.00x
Total	1,812,500	0	217.72x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 217.72x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	396	86,217	217.72x
HNIs (10L +)	3	653	217.67x
HNIs (2-10L)	12	2,613	217.75x
Total Applications	411	89,483	217.72x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Aristo Bio-Tech and Lifescience Limited Public Issue & Market Profile

Aristo Bio-Tech and Lifescience Limited is bringing an initial public offering (IPO) in the Chemicals & Agriculture sector with an aggregate issue size of ₹13.05 Crores. The shares are offered at a price band of ₹72 to ₹72 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2023-01-19, the basis of allotment is scheduled to be finalized on 2023-01-25. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Aristo Bio-Tech and Lifescience Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Aristo Bio-Tech and Lifescience Limited IPO is ₹43 per equity share. Based on the upper price band of ₹72 to ₹72 per equity share, the estimated listing price is ₹115 (+59.7% expected listing gain).

What is the expected profit per lot for Aristo Bio-Tech and Lifescience Limited IPO?

With a lot size of 1600 shares and current GMP of ₹43, the expected profit per application lot is approx ₹68,800 (+59.7% gain). Minimum application cost is approx ₹1,15,200.

What is the issue size and price band for Aristo Bio-Tech and Lifescience Limited IPO?

The Aristo Bio-Tech and Lifescience Limited IPO aggregate issue size is ₹13.05 Crores with an equity price band set at ₹72 to ₹72 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,15,200.

How can I check Aristo Bio-Tech and Lifescience Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 217.72x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Aristo Bio-Tech and Lifescience Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2023-01-25. Investors can verify status using PAN card or application number.

When is the listing date for Aristo Bio-Tech and Lifescience Limited IPO?

Aristo Bio-Tech and Lifescience Limited shares are scheduled to list on NSE on 2023-01-30.